Molecular Health GmbH, a Heidelberg-based biotech firm, filed for insolvency on June 1st, 2026, under self-administration. An investor consortium will take over its core business, continuing...
Evotec SE remains in focus after a turbulent year marked by a profit warning, cyberattack, and leadership change. The Hamburg-based biotech partner works with firms like...